Although IRB recognizes only insulin, its splice variant, IRA, which is most commonly expressed by tumors, also binds to IGF-2 [11] with high affinity, resulting in mitogenic effects and increased survival, motility, and invasiveness of cancer cells [12]. Here, IGF2 is linked to cancer.